Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Queensland Health
Merck
Johnson and Johnson
Moodys
AstraZeneca

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,211,267

« Back to Dashboard

Which drugs does patent 7,211,267 protect, and when does it expire?

Patent 7,211,267 protects ORACEA and is included in one NDA.

This patent has nineteen patent family members in twelve countries.

Summary for Patent: 7,211,267
Title:Methods of treating acne
Abstract:A method of treating acne in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat acne but has substantially no antibiotic activity, without administering a bisphosphonate compound.
Inventor(s): Ashley; Robert A. (Newtown, PA)
Assignee: CollaGenex Pharmaceuticals, Inc. (Newton, PA)
Application Number:10/117,709
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,211,267
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,211,267
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 7,211,267

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galderma Labs Lp ORACEA doxycycline CAPSULE;ORAL 050805-001 May 26, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT OF ONLY INFLAMMATORY LESIONS (PAPULES AND PUSTULES) OF ROSACEA ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 7,211,267

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 330615 ➤ Sign Up
Australia 2002303250 ➤ Sign Up
Canada 2440472 ➤ Sign Up
Canada 2719162 ➤ Sign Up
Germany 60212613 ➤ Sign Up
Denmark 1383508 ➤ Sign Up
European Patent Office 1383508 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Farmers Insurance
Julphar
Merck
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.